Advanced search

Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Labeur, Christine, L LINS, Berlinda Vanloo, J BAERT, R BRASSEUR, and Maryvonne Rosseneu. 1997. “Design of a New Class of Amphipathic Helical Peptides for the Plasma Apolipoproteins That Promote Cellular Cholesterol Efflux but Do Not Activate LCAT.” Arteriosclerosis Thrombosis and Vascular Biology 17 (3): 580–588.
APA
Labeur, C., LINS, L., Vanloo, B., BAERT, J., BRASSEUR, R., & Rosseneu, M. (1997). Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 17(3), 580–588.
Vancouver
1.
Labeur C, LINS L, Vanloo B, BAERT J, BRASSEUR R, Rosseneu M. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1997;17(3):580–8.
MLA
Labeur, Christine, L LINS, Berlinda Vanloo, et al. “Design of a New Class of Amphipathic Helical Peptides for the Plasma Apolipoproteins That Promote Cellular Cholesterol Efflux but Do Not Activate LCAT.” ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 17.3 (1997): 580–588. Print.
@article{182495,
  author       = {Labeur, Christine and LINS, L and Vanloo, Berlinda and BAERT, J and BRASSEUR, R and Rosseneu, Maryvonne},
  issn         = {1079-5642},
  journal      = {ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY},
  language     = {eng},
  number       = {3},
  pages        = {580--588},
  title        = {Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.},
  volume       = {17},
  year         = {1997},
}